TXMD
TherapeuticsMD, Inc.Company with tickers: TXMD
CIK
25743
CUSIP
88338N206
Shares Outstanding
11,574,362
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $724,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $1,447,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Research & Development | — | ||||
| Operating Income | $-723,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Net Income | $95,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| EPS (Basic) | $0.01 | USD/shares | 2026-03-31 | 10-Q | 2026-05-12 |
| EPS (Diluted) | $0.01 | USD/shares | 2026-03-31 | 10-Q | 2026-05-12 |